Remove 2003 Remove Diabetes Remove Labelling
article thumbnail

Paul K Owens, VP of Global Brand Development, Insulins & Glucagon at Eli Lilly & Company Shares Insights from the US FDA Approval of Lyumjev

PharmaShots

Shots: Paul talked about the approval of the Lyumjev Injection for the improvement of glycemic control in children and adolescents with diabetes. Food and Drug Administration (FDA) in June 2020 as a rapid-acting insulin to improve glycemic control in adults with type 1 and type 2 diabetes. of the Lyumjev Injection.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

Through the inclusion of Pharmacia’s products along with a strong performance, Pfizer’s pharmaceutical and animal health revenue was boosted by 40% and 43% respectively In the year 2003, Johnson & Johnson generated a revenue of $41.9B which depicted a growth of 15.3% as compared to the previous year. from last year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A history of Johnson & Johnson

pharmaphorum

Robert Wood’s granddaughter, Mary Lea, was the first baby to be used on the baby powder label. During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. Johnson’s Baby Powder also went on sale during this year and was extremely successful. Acquisitions post-Janssen.

Vaccines 126
article thumbnail

How Balancing Iron Levels Can Help Your Thyroid

The Thyroid Pharmacist

A reinvestigation using Fe-labelling and non-invasive liver iron quantification. Curr Opin Endocrinol Diabetes Obes. National Institute of Diabetes and Digestive and Kidney Diseases. National Institute of Diabetes and Digestive and Kidney Diseases. 1989;114(4 Pt 1):657-663. Iron deficiency in distance runners.